Richa Manwani

1.3k total citations
29 papers, 417 citations indexed

About

Richa Manwani is a scholar working on Molecular Biology, Nephrology and Genetics. According to data from OpenAlex, Richa Manwani has authored 29 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 9 papers in Nephrology and 7 papers in Genetics. Recurrent topics in Richa Manwani's work include Amyloidosis: Diagnosis, Treatment, Outcomes (27 papers), Parathyroid Disorders and Treatments (8 papers) and Neuroendocrine Tumor Research Advances (6 papers). Richa Manwani is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (27 papers), Parathyroid Disorders and Treatments (8 papers) and Neuroendocrine Tumor Research Advances (6 papers). Richa Manwani collaborates with scholars based in United Kingdom, United States and Portugal. Richa Manwani's co-authors include Ashutosh Wechalekar, Philip N. Hawkins, Helen J. Lachmann, Shameem Mahmood, Sajitha Sachchithanantham, Carol Whelan, Julian D. Gillmore, Marianna Fontana, Faye Sharpley and Cristina Quarta and has published in prestigious journals such as Blood, Gut and Annals of the Rheumatic Diseases.

In The Last Decade

Richa Manwani

27 papers receiving 407 citations

Peers

Richa Manwani

GENET

NEPHR

ONCOL

HEMAT

Gabriele Sarais Italy

Karen Wells United States

Cristina Quarta United Kingdom

Ernesto Anesi Italy

Oliver Cohen United Kingdom

Ketna Patel United Kingdom

S. Mahmood United Kingdom

Franco Bergesio Italy

Constantinos Pamboukas Greece

John Townsend United Kingdom

Gabriele Sarais Italy

Richa Manwani

466 ×1.3

129 ×1.1

GENET

137 ×1.2

NEPHR

119 ×1.5

ONCOL

88 ×1.2

HEMAT

Citations per year, relative to Richa Manwani Richa Manwani (= 1×) peers Gabriele Sarais

Countries citing papers authored by Richa Manwani

Since Specialization

Citations

This map shows the geographic impact of Richa Manwani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richa Manwani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richa Manwani more than expected).

Fields of papers citing papers by Richa Manwani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richa Manwani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richa Manwani. The network helps show where Richa Manwani may publish in the future.

Co-authorship network of co-authors of Richa Manwani

This figure shows the co-authorship network connecting the top 25 collaborators of Richa Manwani. A scholar is included among the top collaborators of Richa Manwani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richa Manwani. Richa Manwani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cohen, Oliver, Regina Rendas‐Baum, Kristen McCausland, et al.. (2023). Linking changes in quality of life to haematologic response and survival in systemic immunoglobulin light‐chain amyloidosis. British Journal of Haematology. 201(3). 422–431. 3 indexed citations

Cohen, Oliver, Aviva Petrie, Sriram Ravichandran, et al.. (2022). Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis. Heart. 108(20). 1616–1622. 8 indexed citations

Quarta, Candida Cristina, David F. Hutt, Richa Manwani, et al.. (2021). 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis. European Heart Journal - Cardiovascular Imaging. 22(11). 1304–1311. 42 indexed citations

Sharpley, Faye, Richa Manwani, Aviva Petrie, et al.. (2021). Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first‐line treatment of systemic light chain amyloidosis in the UK. European Journal Of Haematology. 106(4). 537–545. 2 indexed citations

Manwani, Richa, Shameem Mahmood, Sajitha Sachchithanantham, et al.. (2019). Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy. British Journal of Haematology. 187(5). 638–641. 36 indexed citations

Sharpley, Faye, Marianna Fontana, Ana Martinez–Naharro, et al.. (2019). Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria. Haematologica. 105(5). 1405–1413. 10 indexed citations

Sachchithanantham, Sajitha, S. Harrison, Richa Manwani, et al.. (2019). PB2127 BORTEZOMIB-HIGH DOSE METHYLPREDNISOLONE OFFERS IMPROVED HAEMATOLOGICAL RESPONSES AND OVERALL SURVIVAL COMPARED TO BORTEZOMIB-DEXAMETHASONE IN SYSTEMIC LIGHT CHAIN AMYLOIDOSIS. HemaSphere. 3(S1). 958–958. 2 indexed citations

Sharpley, Faye, Marianna Fontana, Janet A. Gilbertson, et al.. (2019). Amyloidosis Diagnosed in Solid Organ Transplant Recipients. Transplantation. 104(2). 415–420. 4 indexed citations

Kotecha, Tushar, Andrea Baggiano, Michele Boldrini, et al.. (2018). Assessment of Treatment Response in Cardiac AL Amyloidosis Using CMR Mapping - Results at 3 Months, 6 Months and 1 Year Post-Chemotherapy. UCL Discovery (University College London). 1 indexed citations

10.

Manwani, Richa, David Wrench, Ashutosh Wechalekar, & Helen J. Lachmann. (2018). Successful treatment of systemic AA amyloidosis associated with underlying Hodgkin lymphoma. British Journal of Haematology. 182(5). 619–619. 2 indexed citations

11.

Sharpley, Faye, Richa Manwani, Shameem Mahmood, et al.. (2018). Real world outcomes of pomalidomide for treatment of relapsed light chain amyloidosis. British Journal of Haematology. 183(4). 557–563. 12 indexed citations

12.

Wagner, Thomas, Joanne Page, Maria Burniston, et al.. (2018). Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds. European Journal of Nuclear Medicine and Molecular Imaging. 45(7). 1129–1138. 26 indexed citations

13.

Manwani, Richa, Ute Hegenbart, Shameem Mahmood, et al.. (2018). Deferred autologous stem cell transplantation in systemic AL amyloidosis. Blood Cancer Journal. 8(11). 101–101. 24 indexed citations

14.

Sharpley, Faye, Richa Manwani, Shameem Mahmood, et al.. (2018). A Novel Mass Spectrometry Method to Identify the Serum Monoclonal Light Chain Component and Infer Organ Involvement in Systemic Light Chain Amyloidosis. Blood. 132(Supplement 1). 4445–4445.

15.

Manwani, Richa, Faye Sharpley, Shameem Mahmood, et al.. (2018). Achieving a Difference in Involved and Uninvolved Light Chains (dFLC) of Less Than 10mg/L Is the New Goal of Therapy in Systemic AL Amyloidosis: Analysis of 916 Patients Treated Upfront with Bortezomib-Based Therapy. Blood. 132(Supplement 1). 3262–3262. 3 indexed citations

16.

Manwani, Richa, Darren Foard, Shameem Mahmood, et al.. (2017). Prolonged Progression Free Survival and Time to Next Treatment Are Achievable Outcomes in Patients with Systemic AL Amyloidosis Treated with Novel Agent Chemotherapy: Analysis of the Alchemy Study. Blood. 130. 1816–1816. 1 indexed citations

17.

Youngstein, Taryn, Janet A. Gilbertson, David F. Hutt, et al.. (2017). Carpal Tunnel Biopsy Identifying Transthyretin Amyloidosis. Arthritis & Rheumatology. 69(10). 2051–2051. 4 indexed citations

18.

Lane, Thirusha, Janet A. Gilbertson, Jennifer H. Pinney, et al.. (2017). THU0076 Disease-modifying treatment regimens have been insufficient to reduce the incidence of systemic aa amyloidosis associated with rheumatoid arthritis in contrast to a significant reduction in those with juvenile idiopathic arthritis. Annals of the Rheumatic Diseases. 76. 227–228. 1 indexed citations

19.

Gordon, Adam, et al.. (2011). Safe discharge of patients with low-risk upper gastrointestinal bleeding (UGIB): Can the use of Glasgow-Blatchford Bleeding Score be extended?. Acute Medicine Journal. 10(4). 176–81. 29 indexed citations

20.

Gordon, Adam, et al.. (2011). Safe discharge of patients with low-risk upper gastrointestinal bleeding (UGIB): can use of Glasgow-Blatchford Bleeding Score (GBS) be extended?: Table 1. Gut. 60(Suppl 1). A42.2–A43. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact